Scarica l'app Stockscreener
10.28
0.10%
0.010
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Omeros Corp Borsa (OMER) Ultime notizie
OMER Stock Surges 5% After Hours On Novo Nordisk Deal Windfall And Drug Launch Optimism - Stocktwits
OMER Stock On Track For Best Week In Nearly 4 Months After Receiving Permanent Reimbursement Code For Treatment - Stocktwits
Heartflow vs. Omeros: Which Healthcare Innovator Stock Is a Better Buy in 2026? - AOL.com
Heartflow vs. Omeros: Which Healthcare Innovator Stock Is a Better Buy in 2026? - The Motley Fool
Omeros shares drop 19% after EMA rejects narsop... - Pluang
Omeros: Yartemlea Faces Headwinds While We Wait On Pipeline Developments - Seeking Alpha
Is Omeros Corporation (OMER) the Best Get Rich Quick Stock to Buy Right Now? - Insider Monkey
Omeros Corporation Files SEC Form 8-K for Other Events – Nasdaq: OMER, July 2026 - Minichart
Omeros to repurchase $16M of 9.50% notes, may buy up to $14.5M more - TradingView
Omeros (NASDAQ: OMER) expands 2029 note repurchases and weighs new debt - Stock Titan
5 Best Get Rich Quick Stocks to Buy Right Now - Insider Monkey
Omeros Corporation Reports First Quarter 2026 Financial Results - The National Law Review
Omeros stock drops 19% after EU rejects key dru... - Pluang
OMEROS CORP (OMER) Stock Chart - ChartMill
Omeros stock crashes on regulatory setback: Buy the dip? - MSN
Biohaven, Goodyear Tire And Other Big Stocks Moving Lower In Monday’s Pre-Market Session - Benzinga
FDA Approved, Europe Unconvinced: Omeros' Stem Cell Transplant Treatment Hits Regulatory Divide - Sahm
Crude Oil Falls 4%; US Consumer Sentiment Rises In June - Sahm
Intellia Therapeutics vs. Omeros: Which Emerging Biotech Stock Is a Better Buy in 2026? - AOL.com
Omeros Corp (OMER) Institutional Confidence - TradingKey
Omeros Corp (OMER) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Omeros Corp (OMER) Valuation: PE, PB & Fair Value Analysis - TradingKey
Omeros (OMER) Faces Regulatory Setback for Narsoplimab Approval - GuruFocus
Omeros stock crashes on regulatory setback: buy the dip? - Invezz
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
OMER Maintained by HC Wainwright & Co. -- Price Target Lowered t - GuruFocus
Why is Omeros stock tumbling today? - Investing.com
Omeros' Stem Cell Transplant Treatment Hits Regulatory DivideOmeros (NASDAQ:OMER) - Benzinga
European regulator issues negative opinion on Omeros’ TA-TMA drug - Investing.com
Omeros Corporation Announces Update on European Marketing Authorization Application for Narsoplimab in TA-TMA - BioSpace
Omeros (OMER) Shares Drop 25% Following EMA Panel's Negative Opi - GuruFocus
Omeros stock tumbles after EMA panel rejects narsoplimab application - Investing.com
Why Is OMER Stock Falling Today? - Yahoo Finance
Omeros EU review turns negative on rare transplant complication drug - Stock Titan
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
ON Semiconductor, SanDisk And Other Big Stocks Moving Lower In Friday’s Pre-Market Session - Benzinga
Omeros stock tumbles after EU panel rejects Yartemlea - Investing.com
Omeros stock tumbles after EU panel rejects Yartemlea By Investing.com - Investing.com UK
OMER Forecast — Price Target — Prediction for 2027 - TradingView
[8-K] OMEROS CORP Reports Material Event - Stock Titan
NovoCure vs. Omeros: Which Emerging Pharmaceutical Stock Is a Better Buy in 2026? - AOL.com
2.64%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):